MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$75,096K
EPS
-$1.88
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
60,263
General and administrative
28,719
Total operating expenses
88,982
Loss from operations
-88,982
Interest income
13,295
Other income
419
Total other income
13,714
Net loss
-75,268
Unrealized gain on marketable securities
172
Total other comprehensive gain
172
Comprehensive loss
-75,096
Basic EPS
-1.88
Diluted EPS
-1.88
Basic Average Shares
39,962,163
Diluted Average Shares
39,962,163
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized gain onmarketable securities$172K Comprehensive loss-$75,096K Total othercomprehensive gain$172K Interest income$13,295K Other income$419K Net loss-$75,268K Total other income$13,714K Loss from operations-$88,982K Total operatingexpenses$88,982K Research and development$60,263K General andadministrative$28,719K

Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION)